NKR 33 Urininkontinens, PICO 2: Bør kvinder med urgency urininkontinens tilbydes

Similar documents
NKR 33 Urininkontinens, PICO 3: Bør kvinder med urininkontinens tilbydes behandling

Characteristics of studies

Female Urinary Incontinence

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

NKR 13 Alkoholbehandling. Disulfiram for alcohol dependency

A review of antimuscarinic prescribing for urinary incontinence in primary care

Question ID: 6 Question type: Intervention Question: Does treatment of overactive bladder symptoms prevent falls in the elderly?

TIBIAL NERVE STIMULATION: ONE OF SEVERAL NEW OPTIONS FOR THE MANAGEMENT OF OVERACTIVE BLADDER IN WOMEN

NKR 33 Urininkontinens, PICO 6: Bør kvinder med stress urininkontinens tilbydes

URINARY INCONTINENCE CASE PRESENTATION #1. Urinary Incontinence - History 2014/10/07. Structure of the Female Lower Urinary Tract

Adult Urodynamics: American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Guideline

Bladder and Bowel Control

Overactive Bladder (OAB)

Familieorienteret alkoholbehandling versus Individuel alkoholbehandling for

KELLI DEWITT WHITEHEAD, RN, MS, ARNP

Bowel and Bladder Dysfunction in MS. Tracy Walker, WOCN, MSCN, FNP C Nurse Practitioner MS Institute at Shepherd Center. Bladder Dysfunction

1 ST JAMAICAN PAEDIATRIC NEPHROLOGY CONFERENCE

PROCEDURE FOR THE ASSESSMENT OF ADULTS AND CHILDREN WITH BLADDER OR BOWEL DYSFUNCTION

SOGC Recommendations for Urinary Incontinence

GENUINE STRESS AND URGE INCONTINENCE PROTOCOL

Urinary Incontinence (Involuntary Loss of Urine) A Patient Guide

Mixed urinary incontinence - sling or not sling

Overactive bladder and urgency incontinence

Combined Effects of Behavioral Intervention and Tolterodine in Patients Dissatisfied With Overactive Bladder Medication

Overactive Bladder (OAB) Content of the lecture

Overview of Urinary Incontinence in the Long Term Care Setting

Classification of Mixed Incontinence

Urinary Incontinence Definitions

Urinary Incontinence

Female Urinary Disorders and Pelvic Organ Prolapse

DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence

Female Urinary Incontinence

A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder

Urinary Incontinence FAQ Sheet

OAB (Overactive Bladder)

Urinary Continence. Second edition FAST FACTS. by Julian Shah and Gary Leach. Anatomy and physiology 7. Investigations and diagnosis 11

Role of the Wound Ostomy Continence Nurse or Continence Care Nurse in Continence Care

Saint Mary s Hospital. Gynaecology Service Warrell Unit. Overactive Bladder. Information for Patients

Gwen Griffith Clinical Nurse Specialist Bolton NHS foundation Trust

Section H Bladder and Bowel

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

URINARY INCONTINENCE IN WOMEN

Primary Care Management Guidelines Female Urinary Incontinence. Overview of Lecture

Fecal incontinence (Encopresis) It is the fecal incontinence condition observed in children with chronic constipation over 1-2 years.

Postoperative. Voiding Dysfunction

Urinary Incontinence in Women. Susan Hingle, M.D. Department of Medicine

BIOFEEDBACK IN THE TREATMENT OF URINARY INCONTINENCE IN ADULTS

Topic review: Clinical presentation and diagnosis of urinary incontinence in the elderly. Prapa Pattrapornpisut 7 June 2012

Posterior Tibial Nerve Stimulation for Voiding Dysfunction. Original Policy Date

Normal bladder function requires a coordinated effort between the brain, spinal cord, and the bladder.

Urinary Incontinence Dr. Leffler

Guideline on the clinical investigation of medicinal products for the treatment of urinary incontinence

Urodynamics in Neuro-Urology

Should SUI Surgery be Combined with Pelvic Organ Prolapse Surgery?

It usually presents with a sudden urge to urinate that is very difficult to delay and may be associated with leakage. Other features include:

Incontinence. What is incontinence?

GLOSSARY of research terms

Case Based Urology Learning Program

Overactive bladder syndrome (OAB)

The overactive bladder and bladder retraining

Efficacy of behavioural training in treating symptoms of urinary urgency and urge urinary incontinence

THE MANAGEMENT OF URINARY INCONTINENCE WITHIN A STROKE UNIT POPULATION REENA DHAMI STROKE CNS EPSOM & ST.HELIER UNIVERSITY HOSPITALS

Bladder and Bowel Assessment Ann Yates Director of Continence Services. 18/07/2008 Cardiff and Vale NHS Trust

Management of Neurogenic Bladder Disorders

THE ROLE OF OVERACTIVE BLADDER TREATMENT

WHAT IS INCONTINENCE?

Urinary incontinence during sexual intercourse: a common, but rarely volunteered, symptom

Enuresis BOWEL AND BLADDER CONTROL. Voiding disorders. Involuntary voiding at an inappropriate time or in a socially unacceptable setting

Managing Changes in Your Bladder Function After Cancer Treatment

Learning Resource Guide. Understanding Incontinence Prism Innovations, Inc. All Rights Reserved

Lower Urinary Tract Symptoms (LUTS) in Middle-Aged and Elderly Men

botulinum toxin type A 50, 100, 200 Allergan units/vial (Botox ) SMC No. (916/13) Allergan Ltd

Stress Urinary Incontinence & The Pelvis

Urinary Incontinence. Patient Information Sheet

Managing Overactive Bladder in Primary care

Urinary incontinence and Prolapse. Dr Zeelha Abdool Consultant OBGYN Steve Biko Academic Hospital

Bladder Health Promotion

CBT versus TAU for ADHD Review information

Non-surgical Treatments for Urinary Incontinence. A Review of the Research for Women

Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

Chapter 3. Urinary incontinence and overactive bladder in community-dwelling women aged years: Risk factors and quality of life.

Urgency and urge incontinence for patients with Multiple Sclerosis Patient Information Leaflet

London New Drugs Group APC/DTC Briefing Document Mirabegron (Betmiga TM ) for overactive bladder March 2013

Urinary Incontinence: an overview!! Neil Harris Consultant Urological Surgeon, Leeds

CARE PROCESS STEP EXPECTATIONS RATIONALE

NHS Professionals. CG8 Guidelines for Continence and Catheter Care. Introduction

PROCEEDINGS INCIDENCE AND PREVALENCE OF STRESS URINARY INCONTINENCE * Ananias C. Diokno, MD ABSTRACT

Peer reviewed Bladder and bowel dysfunction in multiple sclerosis: A review of treatment effectiveness

ACUPUNCTURE AND URINARY INCONTINENCE

Korean Women - Study Proves That Syndrome Does Not Effect on Sexual Life

Urinary Continence Management after a. Stroke. Liz Mackey, CNC Stroke Clinical Coordinator Western Health

Pelvic floor muscle training for urinary incontinence in women

The Efficacy of the Antimuscarinic Drug Oxybutynin in the Treatment Women with Overactive Bladder (OAB) Symptoms

Primary Care management of Overactive Bladder (OAB)

Treatment of urinary incontinence after stroke in adults (Review)

OVERACTIVE BLADDER DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER IN ADULTS:

Suffolk PCT Drug & Therapeutics Committee New Medicine Report

Bladder Health Promotion

URINARY INCONTINENCE Information for Patients and Families Author: Chantale Dumoulin, PhD PT

Transcription:

NKR 33 Urininkontinens, PICO 2: Bør kvinder med urgency urininkontinens tilbydes blæretræning? Review information Authors Sundhedsstyrelsen 1 1 The Danish Health and Medicines Authority Citation example: S. NKR 33 Urininkontinens, PICO 2: Bør kvinder med urgency urininkontinens tilbydes blæretræning? Cochrane Database of Systematic Reviews [Year], Issue [Issue]. Characteristics of studies Characteristics of included studies Fantl 1991 Methods Study design: Randomized controlled trial Study grouping: Parallel group Open Label: Cluster RCT: Participants Baseline Characteristics Intervention Age, mean(sd): 66 (8) Symptoms of stress incontinens, %: 85 Symptom of urge incontinence, %: 57 Use diuretics, %: 35 Control Age, mean(sd): 68 (9) Symptoms of stress incontinens, %: 76 Review Manager 5.3 1

Symptom of urge incontinence, %: 62 Use diuretics, %: 33 Included criteria: Subjects were 55 years or older having at least one episode of involuntary urine loss a week. They lived independently in the community, were mentally intact (Mini-Mental State Examination score>23), and functionally capable of independent or assisted toileting. Excluded criteria: Exclusion criteria were evidence of metabolic decompensation (eg,uncontrolled diabetes mellitus), lower urinary tract infection, urinary obstruction, diverticulum, fistula, reversible cause of Ul (eg, fecal impaction), permanent indwelling catheter, or not fulfilling preestablished objective urodynamic criteria for either DI and/or SI as will be defined. Interventions Intervention Characteristics Intervention Description: Bladder training was based on principles of behavior modification and consisted of a protocol of patient education and a schedule of voluntary micturition. Patient education involved an audiovisual program followed by verbal and written instructions on how to adapt the program to the individual's life-style. The educational program emphasized the neurological (cerebral) control of lower urinary tract function. The voiding schedule consisted initially of micturitions scheduled every 30 or 60 minutes based on the patient's baseline daytime voiding interval.the patient was instructed to 'go to the toilet and empty your bladder as completely as you can' at the scheduled time regardless of the desire to void. Ifur-gencyoccurredprior totheassignedvoiding time, theindividual wasinstructedtosuppresstheurgeaslongaspossibleusingrelaxationanddistrac-tiontechniquesandencouragednottovoi doffschedule.however,iftheur-gencycouldnotbecontrolledandthepatientperceived thatanincontinentepisodewasimminent,shewasnotpro-hibitedfromvoiding.nofluidmodificationswereused.thepatient attendedsix weeklyclinicvisits.eachlastingap-proximately15to20minutes.eachpa-tientkeptdailytreatmentlogs,whichwereassessed attheweeklyclinicvisit.voidingintervalswereprogressivelyincreasedbyaominuteseachweekifthepatientshowedadecrea seinthenum-berofincontinentepisodesandtolerat-edtheschedulewithout interruptions.thegoaloftheprogramwastoreacha2112-to3-hourintervalbetweenvoid-ings.duringeachclinicvisit,complianceandprogresswereassessed.inaddition.positivereinforcementandanexpressionofoptimismforasueeessfuloutcom ewereprovided.followingthe6-weekprogram,eachpatientwasen-couragedtofollowthevoidingschedulemostcomfortabl eforher. Duration treatment: The patient attendedsix weekly clinic visits. each lasting approximately15to 20 minutes. Duration follow up: 6 month (but no control group as they received the intervention after a 6 weeks wait) Control Review Manager 5.3 2

Description: No intervention or clinic contact. Duration treatment: 6 weeks wait, then 6 weeks treatment Duration follow up: 6 month (but no control group as they received the intervention after a 6 weeks wait) Outcomes Antal tilfælde af inkontinens Outcome type: ContinuousOutcome Measure names: ["End of treatment (6 weeks)", "6 months"] Reporting: Fully reported Scale: Antal Unit of measure: Antal Direction: Lower is better Data value: Endpoint Livskvalitet Outcome type: ContinuousOutcome Measure names: ["End of treatment (6 weeks)", "6 months"] Reporting: Fully reported Scale: Incontinence impact quationaire (IIQ-7) Range: 0-3 Direction: Lower is better Data value: Endpoint Frafald Outcome type: AdverseEvent Measure names: ["End of treatment (6 weeks)"] Reporting: Fully reported Scale: Antal Direction: Lower is better Data value: Endpoint Antal vandladninger per døgn Outcome type: ContinuousOutcome Measure names: ["End of treatment (6 weeks)", "6 months"] Reporting: Not reported Review Manager 5.3 3

Patientoplevet effekt Outcome type: ContinuousOutcome Measure names: ["End of treatment (6 weeks)", "6 months"] Reporting: Not reported Antal vandladninger per uge Outcome type: ContinuousOutcome Measure names: ["End of treatment (6 weeks)", "6 months"] Unit of measure: Antal Direction: Lower is better Data value: Endpoint Identification Sponsorship source: This study was supported by Cooperative Agreement AG05170 with the National Institute on Aginriand National Center on Nursing Research, Betheeda,Md. Country: USA Setting: Comments: Authors name: J. Andrew Fantl Institution: Department of Obstetrics and Gynecology Email: Address: Department of Obstetrics and Gynecology, Box 34, MCV Station, Richmond, VA23298 Notes Risk of bias table Bias Authors' judgement Support for judgement Sequence Generation Low risk Quote: "DESIGN AND STATISTICAL ANALYSIS A <b>randomized, controlled design was used. Subjects were stratified into two urodynamic categories: those women with stable detrusor function who had SI, and those with DI with or without concomitant SI (Dl SI). Because the number of wornen with pure DI was expected to be low (approximately 1 0%), statistical power considerations dictated that a separate randomization stratum not be established for them. Within each diagnostic stratum, sub- jects were randomized into the treat ment or control</b> group.treated subjects underwent the 6" Review Manager 5.3 4

Judgement Comment: Probably low risk of due to handmade stratification Allocation concealment Unclear risk Judgement Comment: It is unclear how they concealled the allocation Blinding of participants and personnel High risk Judgement Comment: No details. Probably not blinded - training intervention Blinding of outcome assessors High risk Judgement Comment: This study does not describe the methods for blinding outcome assessors (QoL and antal tilfælde af inkontinens, patient is the outcome assessor) No details. Probably not blinded Selective outcome reporting Low risk Judgement Comment: All outcomes mentioned in the method section were reported on. Other sources of bias Low risk Judgement Comment: No other apparent sources of bias Footnotes References to studies Included studies Fantl 1991 Fantl, J. A.; Wyman, J. F.; McClish, D. K.; Harkins, S. W.; Elswick, R. K.; Taylor, J. R.; Hadley, E. C.. Efficacy of bladder training in older women with urinary incontinence. JAMA 1991;265(5):609-13. [DOI: ] Excluded studies Castleden 1986 Castleden,C. M.; Duffin,H. M.; Gulati,R. S.. Double-blind study of imipramine and placebo for incontinence due to bladder instability. Age and Ageing 1986;15(5):299-303. [DOI: ] Colombo 1995 Colombo,M.; Zanetta,G.; Scalambrino,S.; Milani,R.. Oxybutynin and bladder training in the management of female urinary urge incontinence: A randomized study.. International urogynecology journal and pelvic floor dysfunction 1995;6(2):63-67. [DOI: http://dx.doi.org/10.1007/bf01962573] Review Manager 5.3 5

Jarvis 1980 Jarvis,G. J.; Millar,D. R.. Controlled trial of bladder drill for detrusor instability. British medical journal 1980;281(6251):1322-1323. [DOI: ] Jarvis 1981 Jarvis,G. J.. A controlled trial of bladder drill and drug therapy in the management of detrusor instability. British journal of urology 1981;53(6):565-566. [DOI: ] Mattiasson 2003 Mattiasson,A.; Blaakaer,J.; Hoye,K.; Wein,A. J.; Tolterodine Scandinavian Study Group. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU international 2003;91(1):54-60. [DOI: 3076 [pii]] Szonyi 1995 Szonyi, G.; Collas, D. M.; Ding, Y. Y.; Malone-Lee, J. G.. Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial. 1995;24(4):287-91. [DOI: ] Wallace 2004 Wallace,S. A.; Roe,B.; Williams,K.; Palmer,M.. Bladder training for urinary incontinence in adults. The Cochrane database of systematic reviews 2004;(1)(1):CD001308. [DOI: 10.1002/14651858.CD001308.pub2 [doi]] Wiseman 1991 Wiseman,P. A.; Malone-Lee,J.; Rai,G. S.. Terodiline with bladder retraining for treating detrusor instability in elderly people. BMJ (Clinical research ed.) 1991;302(6783):994-996. [DOI: ] Wyman 1998 Wyman, J. F.; Fantl, J. A.; McClish, D. K.; Bump, R. C.. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. American Journal of Obstetrics & Gynecology 1998;179(4):999-1007. [DOI: S0002937898702066 [pii]] Yoon 2003 Yoon,H. S.; Song,H. H.; Ro,Y. J.. A comparison of effectiveness of bladder training and pelvic muscle exercise on female urinary incontinence. International journal of nursing studies 2003;40(1):45-50. [DOI: S0020748902000317 [pii]] Review Manager 5.3 6

Data and analyses 1 Intervention vs Control Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 1.1 Antal tilfælde af inkontinens pr. uge 1 123 Mean Difference (IV, Fixed, 95% CI) -10.00 [-15.04, -4.96] 1.1.1 End of treatment (6 weeks) 1 123 Mean Difference (IV, Fixed, 95% CI) -10.00 [-15.04, -4.96] 1.2 Livskvalitet 1 82 Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.45, -0.05] 1.2.1 End of treatment (6 weeks) 1 82 Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.45, -0.05] 1.3 Antal vandladninger per døgn 0 0 Mean Difference (IV, Fixed, 95% CI) Not estimable 1.4 Patientoplevet effekt 0 0 Mean Difference (IV, Fixed, 95% CI) Not estimable 1.5 Antal vandladninger per uge 1 123 Mean Difference (IV, Fixed, 95% CI) -5.00 [-12.55, 2.55] 1.5.1 End of treatment (6 weeks) 1 123 Mean Difference (IV, Fixed, 95% CI) -5.00 [-12.55, 2.55] Figures Figure 1 (Analysis 1.1) Review Manager 5.3 7

PICO 2: Forest plot of comparison: 1 Intervention vs Control, outcome: 1.1 Antal tilfælde af inkontinens. Figure 2 (Analysis 1.2) Review Manager 5.3 8

PICO 2: Forest plot of comparison: 1 Intervention vs Control, outcome: 1.2 Livskvalitet. Figure 3 (Analysis 1.5) Review Manager 5.3 9

PICO 2: Forest plot of comparison: 1 Intervention vs Control, outcome: 1.5 Antal vandladninger per uge. Review Manager 5.3 10